Evidence map›Paper›PMID 41883375›Full record

ArticleEnvironment & health (Washington, D.C.)2026

Per- and Polyfluoroalkyl Substance Exposure Associated with Later Puberty in Norwegian Girls: Data from the Bergen Growth Study 2.

Ingvild Halsør Forthun, Mathieu Roelants, Helle Katrine Knutsen, Line Småstuen Haug, Nina Iszatt, Lawrence M Schell, Astanand Jugessur, Kristin Viste, Robert Bjerknes, Ingvild Særvold Bruserud and 1 more

Abstract read
In one paragraph

Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ingvild Halsør ForthunDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway.ORCID https://orcid.org/0000-0001-5577-0553
Mathieu RoelantsDepartment of Public Health and Primary Care, Centre for Environment and Health KU Leuven, 3000 Leuven, Belgium.ORCID https://orcid.org/0000-0002-3749-0475
Helle Katrine KnutsenDepartment of Food Safety, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Line Småstuen HaugDepartment of Food Safety, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Nina IszattDepartment of Food Safety, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Lawrence M SchellDepartment of Epidemiology and Biostatistics, University at Albany, Albany, New York 12144, United States.
Astanand JugessurCentre for Fertility and Health, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Kristin VisteDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway.
Robert BjerknesDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway.
Ingvild Særvold BruserudChildren and Youth Clinic, Haukeland University Hospital, 5021 Bergen, Norway.
Petur Benedikt JuliussonDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFAS) are a group of endocrine-disrupting chemicals, however their effect on pubertal development remains largely unknown. In this cross-sectional study, we examined associations between PFAS exposure and pubertal timing in a cohort of 618 girls aged 6 to 16 years from the Bergen Growth Study 2 in Norway, 2016. Serum concentrations of 19 PFAS were measured, and pubertal development was assessed using several pubertal markers, including ultrasound-assessed breast development, Tanner staging, pubertal hormone levels, and age at menarche. We applied quantile g-computation, elastic net, and Bayesian regression to evaluate both combined and individual effects of PFAS exposure, in addition to single-pollutant analyses. Higher PFAS concentrations were significantly associated with later thelarche, pubarche, lower serum levels of luteinizing hormone, follicle-stimulating hormone, estrone, and estradiol, and later menarche. Among the PFAS analyzed, perfluorooctanesulfonic acid (PFOS) and perfluorodecanoic acid (PFDA) emerged as the key predictors of later pubertal markers. Our results indicate that PFAS exposure is associated with later puberty in girls.

Indexed as

ChildEndocrine disruptionEnvironmental chemicalMenarchePFASPubertal developmentThelarche

Identifiers

PMID41883375
PMCPMC13010314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.